Quantum Biopharma (QNTM) Stock Research

Quantum Biopharma

· QNTM

Dashboard

Financials

Ratios

Valuation

Statistics

27.821 M

-4.94%

Today

Quantum BioPharma signs contract with Thermo Fisher for sclerosis trial

6:05 AM

Over a week ago

Quantum BioPharma licensee Unbuzzed Wellness appoints Zapolin as CEO

QNTM

Sep 24, 8:15 AM

Quantum Group initiated with bullish view at Rodman & Renshaw, here's why

QNTM

Aug 31, 7:09 AM

Quantum Group receives FDA clearance to proceed with Lucid-MS trial

QNTM

Aug 10, 7:25 AM

QNTM Stock trading halted, news pending

QNTM

Jun 1, 7:25 PM

Quantum Group, Massachusetts General Hospital study halfway enrolled

QNTM

May 18, 5:21 AM

Quantum BioPharma submits Lucid-21-302 new drug application to the FDA

QNTM

Apr 1, 8:18 AM

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

QNTM

Mar 30, 8:04 AM

Quantum Group completes dosing in 180-day study of Lucid-MS

QNTM

Dec 23, 8:11 AM

Quantum shareholder files class action lawsuit against the company

QNTM

Dec 22, 7:09 AM

Quantum BioPharma announces airing of news segment on manipulation lawsuit

QNTM

Dec 1, 7:14 AM

Quantum BioPharma sees cash runway beyond March 2027

QNTM

Nov 7, 7:07 AM

Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year

QNTM

Nov 7, 7:06 AM

Quantum BioPharma announces expiration of warrants held by hedge funds

QNTM

Oct 20, 8:36 AM

Quantum responds to allegations made by The Schall Law Firm, DJS Law

QNTM

Oct 14, 8:28 AM

Quantum BioPharma offers cash reward up to $7M for market manipulation proof

QNTM

Oct 8, 8:14 AM

No more stories

Charts